Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangiosarcoma × Interviews as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 17 Breast Neoplasms 14 Prostatic Neoplasms 13 Colorectal Neoplasms 13 Lung Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Malignant Solid Neoplasm 4 Depression 4 Uterine Cervical Neoplasms 3 Lymphoma 3 Hematopoietic and Lymphoid System Neoplasm 3 Hematologic Neoplasms 3 Anxiety Disorders 3 Anatomic Stage I Breast Cancer AJCC v8 3 Advanced Malignant Solid Neoplasm 3 Urinary Bladder Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Motor Activity 2 Leukemia 2 Laryngeal Neoplasms 2 Head and Neck Carcinoma 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2

Interventions

Doxorubicin 16 Ifosfamide 10 pazopanib 6 Radiotherapy 6 Paclitaxel 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Docetaxel 3 trebananib 2 cixutumumab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Conformal 2 Magnetic Resonance Spectroscopy 2 Etoposide 2 Epirubicin 2 Chemotherapy, Adjuvant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡